Wanxiang Niu

773 total citations
24 papers, 559 citations indexed

About

Wanxiang Niu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Wanxiang Niu has authored 24 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Wanxiang Niu's work include MicroRNA in disease regulation (8 papers), Glioma Diagnosis and Treatment (6 papers) and Circular RNAs in diseases (6 papers). Wanxiang Niu is often cited by papers focused on MicroRNA in disease regulation (8 papers), Glioma Diagnosis and Treatment (6 papers) and Circular RNAs in diseases (6 papers). Wanxiang Niu collaborates with scholars based in China and France. Wanxiang Niu's co-authors include Shanshan Hu, Chaoshi Niu, Xiaoming Zhang, Chaoshi Niu, Yongfei Dong, Xueran Chen, Zhiyou Fang, Xiaoqing Fan, Chuandong Cheng and Chenggang Zhao and has published in prestigious journals such as Oncogene, International Journal of Radiation Oncology*Biology*Physics and Cell Death and Disease.

In The Last Decade

Wanxiang Niu

23 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanxiang Niu China 13 432 360 58 44 40 24 559
Fangcheng Li China 12 397 0.9× 291 0.8× 77 1.3× 76 1.7× 51 1.3× 31 578
Zhifei Wang China 13 424 1.0× 303 0.8× 38 0.7× 54 1.2× 29 0.7× 24 535
Yutian Wei China 11 677 1.6× 566 1.6× 56 1.0× 71 1.6× 70 1.8× 19 839
Alessia Catania Italy 10 366 0.8× 246 0.7× 59 1.0× 36 0.8× 34 0.8× 16 488
Bin Yuan China 11 366 0.8× 240 0.7× 73 1.3× 26 0.6× 43 1.1× 22 498
Xiaobai Liu China 14 495 1.1× 432 1.2× 25 0.4× 30 0.7× 36 0.9× 19 592
Yixue Xue China 16 460 1.1× 359 1.0× 47 0.8× 54 1.2× 35 0.9× 22 583
Bingxi Lei China 13 405 0.9× 283 0.8× 70 1.2× 128 2.9× 65 1.6× 28 602
Tianshi Que China 8 351 0.8× 248 0.7× 64 1.1× 50 1.1× 60 1.5× 15 480

Countries citing papers authored by Wanxiang Niu

Since Specialization
Citations

This map shows the geographic impact of Wanxiang Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanxiang Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanxiang Niu more than expected).

Fields of papers citing papers by Wanxiang Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanxiang Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanxiang Niu. The network helps show where Wanxiang Niu may publish in the future.

Co-authorship network of co-authors of Wanxiang Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanxiang Niu. A scholar is included among the top collaborators of Wanxiang Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanxiang Niu. Wanxiang Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoming, Wanxiang Niu, Ben Xu, et al.. (2025). CircPRKD3-loaded exosomes concomitantly elicit tumor growth inhibition and glioblastoma microenvironment remodeling via inhibiting STAT3 signaling. Neuro-Oncology. 27(8). 1987–2005. 4 indexed citations
2.
3.
Niu, Wanxiang, et al.. (2024). Lycorine hydrochloride interferes with energy metabolism to inhibit chemoresistant glioblastoma multiforme cell growth through suppressing PDK3. Molecular and Cellular Biochemistry. 480(1). 355–369. 3 indexed citations
4.
Chen, Yinan, et al.. (2023). GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma. Cancer Gene Therapy. 30(12). 1702–1714. 4 indexed citations
5.
Zhang, Siyu, et al.. (2023). Blocking Palmitoylation of Apelin Receptor Alleviates Morphine Tolerance in Neuropathic Cancer Pain. International Journal of Biological Sciences. 20(1). 47–60. 7 indexed citations
6.
Fan, Xiaoqing, et al.. (2023). Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation. Molecular Neurobiology. 60(6). 3452–3463. 7 indexed citations
7.
Niu, Wanxiang, et al.. (2023). CircSOBP suppresses the progression of glioma by disrupting glycolysis and promoting the MDA5-mediated immune response. iScience. 26(10). 107897–107897. 13 indexed citations
8.
Dong, Yongfei, et al.. (2022). Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations. Analytical Cellular Pathology. 2022. 1–7. 4 indexed citations
9.
Fan, Xiaoqing, Haoran Yang, Huihui Ma, et al.. (2022). SETD2 Palmitoylation Mediated by ZDHHC16 in Epidermal Growth Factor Receptor-Mutated Glioblastoma Promotes Ionizing Radiation-Induced DNA Damage. International Journal of Radiation Oncology*Biology*Physics. 113(3). 648–660. 25 indexed citations
10.
Zhang, Ning, et al.. (2022). Exosomal miR-155-5p derived from glioma stem-like cells promotes mesenchymal transition via targeting ACOT12. Cell Death and Disease. 13(8). 725–725. 30 indexed citations
11.
Zhao, Chenggang, Xiaoqing Fan, Wanxiang Niu, et al.. (2022). GSK3β palmitoylation mediated by ZDHHC4 promotes tumorigenicity of glioblastoma stem cells in temozolomide-resistant glioblastoma through the EZH2–STAT3 axis. Oncogenesis. 11(1). 28–28. 23 indexed citations
12.
Qi, Jian, Chenggang Zhao, Wanxiang Niu, et al.. (2022). Systematic transcriptome profiling of pyroptosis related signature for predicting prognosis and immune landscape in lower grade glioma. BMC Cancer. 22(1). 885–885. 3 indexed citations
13.
Fan, Xiaoqing, Haoran Yang, Chenggang Zhao, et al.. (2021). Heterogeneity of subsets in glioblastoma mediated by Smad3 palmitoylation. Oncogenesis. 10(10). 72–72. 26 indexed citations
14.
15.
Zhang, Xiaoming, et al.. (2020). Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop. Journal of Experimental & Clinical Cancer Research. 39(1). 196–196. 62 indexed citations
16.
Chen, Cheng, Hong Wu, Zuowei Wang, et al.. (2020). Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway. Acta Pharmacologica Sinica. 42(1). 108–114. 25 indexed citations
17.
Cheng, Chuandong, Yongfei Dong, Wanxiang Niu, & Chaoshi Niu. (2020). HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG. Pathology - Research and Practice. 216(4). 152883–152883. 10 indexed citations
18.
Niu, Wanxiang, et al.. (2018). Effects of lentivirus-mediated CYP17A1 gene silencing on the biological activity of glioma. Neuroscience Letters. 692. 210–215. 2 indexed citations
19.
Qin, Yuanyuan, Weilong Chen, Bingjie Liu, et al.. (2017). MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin. Theranostics. 7(6). 1663–1673. 37 indexed citations
20.
Li, Dongxue, Yongfei Dong, Chuandong Cheng, et al.. (2017). The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2. Oncotarget. 8(50). 88163–88178. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fangcheng Li Breakdown of academic impact, for papers by Zhifei Wang Breakdown of academic impact, for papers by Yutian Wei Breakdown of academic impact, for papers by Alessia Catania Breakdown of academic impact, for papers by Bin Yuan Breakdown of academic impact, for papers by Xiaobai Liu Breakdown of academic impact, for papers by Yixue Xue Breakdown of academic impact, for papers by Bingxi Lei Breakdown of academic impact, for papers by Tianshi Que
Rankless by CCL
2026